BOARD OF DIRECTORS

As a QHP Capital Strategic Advisor, Mike offers over 35 years of experience in the pharmaceutical, biologics, and medical device industries, with a focus on product development and regulatory sciences. He has worked on numerous approved NDAs, ANDA, BLAs, and MAAs. Mike’s company, Beckloff Associates, a preeminent global scientific and regulatory consulting group, employed over 100 pharmaceutical and regulatory scientists, providing services to over 200 clients worldwide, ranging from large pharma and biopharma companies to small start-up operations. Cardinal Health acquired Beckloff Associates in 2004, where Mike continued until co-founding Silvergate Pharmaceuticals in 2010. Mike was the Chief Development Officer at Silvergate and then Azurity Pharmaceuticals following the acquisition of Silvergate Pharmaceuticals in 2019.

Mike received his Cellular Biology Degree from the University of Kansas.